Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?

Aim:  Atrial fibrillation (AF) is common in haemodialysis patients, but the risks and benefits of anticoagulation in this group are not well characterized. We investigated the prevalence of AF, its associated risk factors, and the incidence of stroke and haemorrhage in a cohort of haemodialysis patients.

[1]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[2]  A. Yıldırır,et al.  Frequency of atrial fibrillation and factors related to its development in dialysis patients. , 2006, International journal of cardiology.

[3]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  M. Valsecchi,et al.  Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  S. Ibayashi,et al.  Stroke in patients on maintenance hemodialysis: a 22-year single-center study. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  B. Kestenbaum,et al.  Risk factors for incident stroke among patients with end-stage renal disease. , 2003, Journal of the American Society of Nephrology : JASN.

[7]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  M. Borrego,et al.  Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? , 2003, International journal of cardiology.

[9]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[10]  J. Cox,et al.  Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. , 2001, BMJ : British Medical Journal.

[11]  J. McNeil,et al.  Incidence of the Major Stroke Subtypes: Initial Findings From the North East Melbourne Stroke Incidence Study (NEMESIS) , 2001, Stroke.

[12]  P. Balcke,et al.  Incidence of Stroke among Chronic Hemodialysis Patients with Nonrheumatic Atrial Fibrillation , 2001, American Journal of Nephrology.

[13]  D. Feinfeld,et al.  SYMPTOMATIC ATRIAL ARRHYTHMIAS IN HEMODIALYSIS PATIENTS , 2001, Renal failure.

[14]  M. Borrego,et al.  Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. , 2000, American heart journal.

[15]  K. Iseki,et al.  Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  D. Di Landro,et al.  Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. , 2000, Clinical nephrology.

[17]  G. Sachdev,et al.  Review of the Fifth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy: outpatient management for adults. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[18]  A. Ciucci,et al.  Left Ventricular Hypertrophy in Daily Dialysis , 1999, Mineral and Electrolyte Metabolism.

[19]  Rose Anne Kenny,et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[20]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[21]  Y. Yamamoto,et al.  Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  David M. Smith,et al.  Risk of major hemorrhage for outpatients treated with warfarin , 1998, Journal of General Internal Medicine.

[23]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[24]  K. Iseki,et al.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.

[25]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[26]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[27]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  C. Clase,et al.  Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management. , 2006, Thrombosis research.

[29]  S. Ertürk.  Long-term evolution of cardiomyopathy in dialysis patients. , 1999, Kidney international.

[30]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[31]  D. Glassford,et al.  The risk of anticoagulation in hemodialysis patients. , 1977, Nephron.

[32]  N. Niikawa,et al.  Origin of triploidy and tetraploidy in man: 11 cases with chromosomes markers. , 1977, Cytogenetics and cell genetics.